End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.30 CNY | -1.40% |
|
-2.75% | -5.36% |
01-22 | Shyndec Pharma's Units Get Three Drug Registration Certificates | MT |
01-20 | Shanghai Shyndec's Shenzhen Unit Passes EU GMP Inspection | MT |
Evolution of the Average Target: Shanghai Shyndec Pharmaceutical Co., Ltd.
Evolution of the Target Price: Shanghai Shyndec Pharmaceutical Co., Ltd.
Changes in Analyst Recommendations: Shanghai Shyndec Pharmaceutical Co., Ltd.
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
- | - | +72.74% | ||||
+32.76% | ||||||
+12.26% | ||||||
+44.13% | ||||||
+10.23% | ||||||
+13.24% | ||||||
+17.74% | ||||||
+8.18% | ||||||
Average | +26.41% | |||||
Weighted average by Cap. | +29.01% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
- Consensus Shanghai Shyndec Pharmaceutical Co., Ltd.

MarketScreener is also available in this country: United States.
Switch edition